Majority of Women Prefer Abbreviated Breast MRI Screening
By MedImaging International staff writers Posted on 24 Nov 2021 |
Image: AB-MRI (R) reveals a 10mm mass, not seen on mammogram (L) due to marked breast density (Photo courtesy of St. Vincent`s Private Hospital)
A new study reveals that abbreviated Breast MRI (AB-MRI) is well tolerated, with 75% of surveyed patients selecting it as their preferred modality for screening.
The survey, conducted among 200 asymptomatic patients at average to mildly elevated risk of breast cancer at St. Vincent's Private Hospital (Sydney, Australia), included 199 women and one man (mean age 53 years), of whom 86% were classified as BIRADS 1 and 2, and 14% being BIRADS 3-5. All exams were performed on a 3-tesla MRI scanner using dedicated breast coils with patients in the prone position; 7.5 ml of intravenous gadobutrol was administered during the exam. In all, 155 patients were recommended to return to routine screening, and 28 patients (identified as BIRADS ≥ three) were recommended for further investigations.
AB-MRI screened identified nine breast cancers in eight patients, for a cancer detection rate of 4.5%, and a positive predictive value (PPV) 44% higher than screening mammography; cancer detection was not limited by breast density. Overall, 63% of patients preferred AB-MRI screening, while 21% preferred mammography; 16% said they were unable to compare the two techniques. IV contrast administration was rated as an excellent/good experience by 68%. The study was presented at the virtual Royal Australian & New Zealand College of Radiology (RANZCR) annual scientific meeting.
“AB-MR was well tolerated by patients, with 75% of surveyed patients selecting it as their preferred modality for screening,” concluded senior author Linda Borella, MD, and colleagues. “The results of this study may be used to inform further research to assess the cost-effectiveness of abbreviated breast MRI for wider population-based screening and to support the incorporation of abbreviated breast MRI into Australian breast cancer screening guidelines.”
Breast MRI has the highest cancer detection rate of all breast imaging exams across all breast density categories. Traditionally, breast MRI has been reserved for high-risk women due to the cost, length of exam, and availability of interpretation time. AB-MRI is a shortened version of breast MRI that is designed to detect biologically aggressive invasive cancers and high-grade ductal carcinoma in situ (DCIS) at early stages. The sensitivity of AB-MRI is comparable to that of conventional MRI.
Related Links:
St. Vincent's Private Hospital
The survey, conducted among 200 asymptomatic patients at average to mildly elevated risk of breast cancer at St. Vincent's Private Hospital (Sydney, Australia), included 199 women and one man (mean age 53 years), of whom 86% were classified as BIRADS 1 and 2, and 14% being BIRADS 3-5. All exams were performed on a 3-tesla MRI scanner using dedicated breast coils with patients in the prone position; 7.5 ml of intravenous gadobutrol was administered during the exam. In all, 155 patients were recommended to return to routine screening, and 28 patients (identified as BIRADS ≥ three) were recommended for further investigations.
AB-MRI screened identified nine breast cancers in eight patients, for a cancer detection rate of 4.5%, and a positive predictive value (PPV) 44% higher than screening mammography; cancer detection was not limited by breast density. Overall, 63% of patients preferred AB-MRI screening, while 21% preferred mammography; 16% said they were unable to compare the two techniques. IV contrast administration was rated as an excellent/good experience by 68%. The study was presented at the virtual Royal Australian & New Zealand College of Radiology (RANZCR) annual scientific meeting.
“AB-MR was well tolerated by patients, with 75% of surveyed patients selecting it as their preferred modality for screening,” concluded senior author Linda Borella, MD, and colleagues. “The results of this study may be used to inform further research to assess the cost-effectiveness of abbreviated breast MRI for wider population-based screening and to support the incorporation of abbreviated breast MRI into Australian breast cancer screening guidelines.”
Breast MRI has the highest cancer detection rate of all breast imaging exams across all breast density categories. Traditionally, breast MRI has been reserved for high-risk women due to the cost, length of exam, and availability of interpretation time. AB-MRI is a shortened version of breast MRI that is designed to detect biologically aggressive invasive cancers and high-grade ductal carcinoma in situ (DCIS) at early stages. The sensitivity of AB-MRI is comparable to that of conventional MRI.
Related Links:
St. Vincent's Private Hospital
Latest MRI News
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods
- DW-MRI Lights up Small Ovarian Lesions like Light Bulbs
- Abbreviated Breast MRI Effective for High-Risk Screening without Compromising Diagnostic Accuracy